Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Adaptive Biotechnologies Corporation (ADPT) had Current Assets of $300.19M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$276.98M |
|
$-59.50M |
|
$71.36M |
|
$205.62M |
|
$334.10M |
|
$-57.12M |
|
$-2.33M |
|
$-59.46M |
|
$-59.46M |
|
$-59.46M |
|
$-59.46M |
|
$-59.46M |
|
$-59.46M |
|
$-57.12M |
|
$-41.80M |
|
151.72M |
|
151.72M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
|
Current Assets |
$300.19M |
$34.11M |
|
$212.55M |
|
$512.74M |
|
$89.92M |
|
-- |
|
$197.82M |
|
$287.74M |
|
$225.00M |
|
$104.30M |
|
$225.00M |
|
153.78M |
|
| Cash Flow Statement Financials | |
$-45.99M |
|
$37.95M |
|
$30.40M |
|
$50.82M |
|
$73.18M |
|
$22.37M |
|
$51.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
74.24% |
|
-20.62% |
|
-20.62% |
|
-15.09% |
|
-21.47% |
|
-21.48% |
|
$-48.95M |
|
-- |
|
-- |
|
-- |
|
0.54 |
|
7.27 |
|
5.50 |
|
66.37 |
|
-26.43% |
|
-57.00% |
|
-11.60% |
|
-26.43% |
|
$1.46 |
|
$-0.32 |
|
$-0.30 |
|